Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Thrombosis Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.THROMRES.2007.04.014PMID 17582471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission

  2005cited by this paper
• Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies

  2005cited by this paper
• Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies.

  2005cited by this paper
• Endothelial microparticles as markers of endothelial dysfunction.

  2004cited by this paper
• Measuring circulating cell‐derived microparticles

  2004cited by this paper
• High levels of circulating endothelial microparticles in patients with acute coronary syndromes.

  2003cited by this paper
• Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation

  2003cited by this paper
• Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease

  2003cited by this paper
• Antiphospholipid antibodies: discovery, definitions, detection and disease.

  2003cited by this paper
• Factor VII/VIIa: a new antigen in the anti‐phospholipid antibody syndrome

  2003cited by this paper
• Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.

  2003cited by this paper
• E‐Selectin mediates pathogenic effects of antiphospholipid antibodies

  2003cited by this paper
• Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group.

  2002cited by this paper
• The antiphospholipid syndrome.

  2002cited by this paper
• Antiphospholipid Syndrome: Diagnostic Aspects of Lupus Anticoagulants

  2001cited by this paper
• Anticardiolipin Antibody Assay: a Methodological Analysis for a better Consensus in Routine Determinations

  2001cited by this paper
• Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease

  2001cited by this paper
• Antiphospholipid antibodies and the endothelium.

  2001cited by this paper
• Elevated plasma endothelial microparticles in multiple sclerosis

  2001cited by this paper
• Validation of the Sapporo criteria for antiphospholipid syndrome.

  2000cited by this paper
• Detection of Complement-fixing Antiphospholipid Antibodies in Association with Thrombosis

  2000cited by this paper
• Systemic Endothelial Cell Markers in Primary Antiphospholipid Syndrome

  2000cited by this paper
• Platelet Activation Induced by Combined Effects of Anticardiolipin and Lupus Anticoagulant IgG Antibodies in Patients with Systemic Lupus Erythematosus

  1999cited by this paper
• IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner.

  1999cited by this paper
• Antiphospholipid antibodies and thrombosis.

  1999cited by this paper
• Platelet microparticles: a wide-angle perspective.

  1999cited by this paper
• Lupus Anticoagulant Testing in Europe: An Analysis of Results from the First European Concerted Action on Thrombophilia (ECAT) Survey Using Plasmas Spiked with Monoclonal Antibodies against Human β2-Glycoprotein I

  1999cited by this paper
• Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome.

  1999cited by this paper
• Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-infiammatory phenotype in vitro

  1999cited by this paper
• Anti‐endothelial cell antibodies in primary antiphospholipid syndrome and SLE: patterns of reactivity with membrane antigens on microvascular and umbilical venous cell membranes

  1998cited by this paper
• Primary recurrent miscarriages: anti-beta2-glycoprotein I IgG antibodies induce an acquired activated protein C resistance that can be detected by the modified activated protein C resistance test.

  1998cited by this paper
• Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C.

  1998cited by this paper
• Antibody-Mediated Thrombosis

  1997cited by this paper
• Antiphospholipid antibody‐dependent C5b‐9 formation

  1997cited by this paper
• Thrombogenic Mechanisms of Antiphospholipid Antibodies

  1997cited by this paper
• Antiphospholipid Antibodies: Predictive Value of Laboratory Tests

  1997cited by this paper
• Immunology of the antiphospholipid antibody syndrome.

  1996cited by this paper
• Increased Plasma Thrombomodulin in Different Subgroups of Patients with Antiphospholipid and Anti β2 Glycoprotein I Antibodies

  1996cited by this paper
• Antiphospholipid Antibodies Activate Vascular Endothelial Cells

  1996cited by this paper
• Specific Cross-reaction of IgG Anti-phospholipid Antibody with Platelet Glycoprotein IIIa

  1996cited by this paper
• Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus

  1996cited by this paper
• Do some antiphospholipid antibodies target endothelial cells?

  1996cited by this paper
• Criteria for the Diagnosis of Lupus Anticoagulants: An Update

  1995cited by this paper
• Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

  1995cited by this paper
• Protean Clinical Presentation of Antiphospholipid-Protein Antibodies (APA)

  1995cited by this paper
• Syndromes of Hypercoagulability and Thrombosis: A Review

  1994cited by this paper
• Antiphospholipid antibodies and thrombosis.

  1994cited by this paper
• Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?

  1993cited by this paper
• Antiphospholipid Antibodies Enhance Thrombin-Induced Platelet Activation and Thromboxane Formation

  1993cited by this paper
• Antiphospholipid Antibody Positive Sera Enhance Endothelial Cell Procoagulant Activity – Studies in a Thrombosis Model

  1992cited by this paper
• Relationship between anti-phospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells.

  1992cited by this paper
• Antibodies to platelets in patients with anti-phospholipid antibodies.

  1991cited by this paper
• Detection of endothelial cell‐reactive immunoglobulin in patients with anti‐phospholipid antibodies

  1991cited by this paper
• Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.

  1988cited by this paper
• The anticardiolipin syndrome.

  1985cited by this paper

• Extracellular Vesicles Analysis as Possible Signatures of Antiphospholipid Syndrome Clinical Features

  2025cites this paper
• Association between extracellular vesicles (EVs) and thrombosis in antiphospholipid syndrome

  2025cites this paper
• The convergent model of coagulation.

  2024cites this paper
• Thrombocytopenia in primary antiphospholipid syndrome: Association with prognosis and clinical implications.

  2022cites this paper
• Platelet- and endothelial-derived microparticles in the context of different antiphospholipid antibody profiles

  2022cites this paper
• Pathophysiology of Antiphospholipid Syndrome

  2021cites this paper
• Thrombosis and Haemostasis Pathophysiology of the Antiphospholipid Antibody Syndrome

  2021cites this paper
• Extracellular Vesicles and Antiphospholipid Syndrome: State-of-the-Art and Future Challenges

  2021cites this paper
• Laboratory Approaches to Test the Function of Antiphospholipid Antibodies

  2021cites this paper
• Extracellular Vesicles: Intercellular Communication Mediators in Antiphospholipid Syndrome

  2021cites this paper
• Platelet distribution width is highly associated with thrombotic events in primary antiphospholipid syndrome

  2021cites this paper
• Anti-β2-glycoprotein I autoantibodies influence thrombin generation parameters via various mechanisms.

  2020cites this paper
• Expression of tissue factor mRNA in thrombosis associated with antiphospholipid syndrome

  2020cites this paper
• Characterization of Plasma-Derived Small Extracellular Vesicles Indicates Ongoing Endothelial and Platelet Activation in Patients with Thrombotic Antiphospholipid Syndrome

  2020cites this paper
• Microparticles in systemic sclerosis, targets or tools to control fibrosis: This is the question!

  2019cites this paper
• Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings.

  2019cites this paper
• From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders

  2018cites this paper
• ncreased Concentrations of Soluble CD 40 Ligand Platelet in Patients With rimary Antiphospholipidic Syndrome

  2018cites this paper
• Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies.

  2017cites this paper
• Extracellular Vesicles in the Antiphospholipid Syndrome

  2017cites this paper
• Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: a role for circulating microparticles?

  2017cites this paper
• Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers

  2017cites this paper
• IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis

  2016cites this paper
• Microparticle analysis in disorders of hemostasis and thrombosis

  2016cites this paper
• Higher levels of procoagulant microparticles in women with recurrent miscarriage are not associated with antiphospholipid antibodies.

  2016cites this paper
• Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment.

  2016cites this paper
• Role of extracellular vesicles in autoimmune diseases.

  2016cites this paper
• Endothelial microparticles: Pathogenic or passive players in endothelial dysfunction in autoimmune rheumatic diseases?

  2016cites this paper
• Extracellular Vesicles: Evolving Contributors in Autoimmunity.

  2015cites this paper
• The Role of Blood-Borne Microparticles in Inflammation and Hemostasis

  2015cites this paper
• The Journey of Antiphospholipid Antibodies From Cellular Activation to Antiphospholipid Syndrome

  2015cites this paper
• The Pathophysiology of Antiphospholipid Syndrome

  2015cites this paper
• Microparticles: Bridging the Gap between Autoimmunity and Thrombosis

  2015cites this paper
• A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies.

  2015cites this paper
• Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.

  2015cites this paper
• Endothelial and platelet microparticles in patients with antiphospholipid antibodies.

  2015influential citation
• Biological Impact of Membranous Nanostructures

  2015cites this paper
• Formation of Microparticles in the Injured Brain of Patients with Severe Isolated Traumatic Brain Injury

  2014cites this paper
• Évaluation de la fonction endothéliale au cours des maladies auto-immunes

  2014cites this paper
• O fator de von Willebrand, ligação com fator VIII e estudo da atividade da ADAMTS-13 em pacientes com síndrome antifosfolípide primária

  2014cites this paper
• [Assessment of endothelial function in autoimmune diseases].

  2014cites this paper
• Platelets in rheumatic diseases: friend or foe?

  2014cites this paper
• Increased concentrations of soluble CD40 ligand platelet in patients with primary antiphospholipidic syndrome.

  2013cites this paper
• Cell-derived microparticles and vascular pregnancy complications: a systematic and comprehensive review.

  2013cites this paper
• Incremento en las concentraciones de ligando CD40 soluble plaquetario en pacientes con síndrome antifosfolipídico primario

  2013cites this paper
• From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome.

  2013cites this paper
• Sejt-eredetű extracelluláris vezikulák mérését befolyásoló preanalitikai és analitikai tényezők vizsgálata

  2013cites this paper
• The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes

  2012cites this paper
• 1 Microparticles : Role in Haemostasis and Venous Thromboembolism

  2012cites this paper
• In vitro effect of anti-β₂ glycoprotein I antibodies on P-selectin expression, a marker of platelet activation.

  2012cites this paper
• Leukocyte-and endothelial-derived microparticles : a circulating source for fibrinolysis by

  2012influential citation
• Leukocyte-and endothelial-derived microparticles : a circulating source for fibrinolysis by

  2012influential citation
• Lupus Anticoagulants, Antiphospholipid Antibodies, and Antiphospholipid Syndrome

  2012cites this paper
• Studio dell'attivazione piastrinica ed endoteliale in pazienti con sindrome da anticorpi antifosfolipidi ad alto rischio in trattamento aferetico

  2012cites this paper
• Microparticles: Role in Haemostasis and Venous Thromboembolism

  2012cites this paper
• Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis

  2012influential citation
• Endothelial microparticle release is stimulated in vitro by purified IgG from patients with the antiphospholipid syndrome

  2012cites this paper
• Studies of microparticles in patients with the antiphospholipid syndrome (APS)

  2012cites this paper
• Evaluation of Circulating Endothelial and Platelet Microparticles in Men with Ankylosing Spondylitis

  2012cites this paper
• Ankylosing Spondylitis Evaluation of Circulating Endothelial and Platelet Microparticles in Men with

  2012cites this paper
• Platelet-Derived Microvesicles: Multitalented Participants in Intercellular Communication

  2012cites this paper
• Circulating microparticles in systemic Lupus Erythematosus.

  2012cites this paper
• Pathophysiological mechanisms in antiphospholipid syndrome.

  2011cites this paper
• Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.

  2011cites this paper
• Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factors.

  2011cites this paper
• Risk of recurrent thrombosis related to antiphospholipid antibodies , soluble CD 40 L and P selectin serum levels in patients with antiphospholipid syndrome secondary to systemic lupus eritematosus

  2011cites this paper
• The role of microparticles in the pathogenesis of rheumatic diseases

  2010cites this paper
• Phagocytosis of platelet microvesicles and β2– glycoprotein I

  2010cites this paper
• What nephrologists need to know about antiphospholipid syndrome.

  2010cites this paper
• Human plasma membrane-derived vesicles inhibit the phagocytosis of apoptotic cells--possible role in SLE.

  2010cites this paper
• Flow cytometric analysis of circulating microparticles in plasma

  2010cites this paper
• Antiphospholipid antibodies: Paradigm in transition

  2009cites this paper
• Thrombin Binding Predicts the Effects of Sequence Changes in a Human Monoclonal Antiphospholipid Antibody on Its In Vivo Biologic Actions 1

  2009cites this paper
• Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?

  2009cites this paper
• Effects of Low‐Molecular‐Weight Heparin on Adhesion and Vesiculation of Phospholipid Membranes

  2009cites this paper
• Circulating microparticles, lupus anticoagulant and recurrent miscarriages.

  2009cites this paper
• Cell-derived microparticles in haemostasis and vascular medicine

  2009cites this paper
• Blood and Synovial Microparticles as Revealed by Atomic Force and Scanning Electron Microscope

  2009cites this paper
• Late Thrombosis of Sirolimus-Eluting Stent: A Multifactorial Problem

  2009cites this paper
• S.93. Characterization of Tumor-derived Exosomes and Their Role in Immunoregulation

  2009cites this paper
• Chapter 5 Tissue Factor in Antiphospholipid Antibody-induced Pregnancy Loss: Thrombosis versus Inflammation

  2009cites this paper
• Immunohistochemical detection of intravascular platelet microthrombi in patients with lupus nephritis and anti-phospholipid antibodies.

  2009cites this paper
• Superficial femoral artery thrombosis as a cause for distal embolism in primary antiphospholipid syndrome.

  2008cites this paper
• Tissue factor-bearing microparticles and cancer.

  2008cites this paper
• Tissue Factor–Bearing Microparticles and Cancer

  2008cites this paper
• Endothelial cell activation by immunoglobulins from patients with immune thrombocytopenic purpura or with antiphospholipid syndrome

  2008cites this paper
• The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation

  2008cites this paper
• Pathophysiology of the antiphospholipid syndrome

  2005cites this paper
• Biologic Actions Antiphospholipid Antibody on Its in Vivo Sequence Changes in a Human Monoclonal Thrombin Binding Predicts the Effects Of

  year unknowncites this paper